ingredient Sofosbuvir 400mg and Velpatasvir 100mg (EPCLUSA)
substitutes Epclusa 28s, Hepcvel 28s, Panovir 28s, Sofosvel 6s, Sovihep V 28s, VelaKast 28s, VelaSof 28s, Velpaclear 28s, Virvel 28s, Velpanat 28s
treatment Chronic hepatitis C virus (HCV) infection
Shipping class Room Temperature
Medicine Overview by Anukar Pharmacy
( MyHep All 28 Tablet, Mylan )
TreatmentMyHep All Tablet is used in the treatment of chronic hepatitis C virus (HCV) infection.
Side EffectsHeadache, Tiredness.
Method of UseTake this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. MyHep All Tablet may be taken with or without food, but it is better to take it at a fixed time.
How MyHep All 28 Tablet, Mylan WorksMyHep All Tablet is a combination of two antiviral medicines: Sofosbuvir and Velpatasvir. They work by lowering the amount of hepatitis C virus in the body and removing the virus from the blood over a period of time.
Warning by Anukar Pharmacy
( MyHep All 28 Tablet, Mylan )
Special precautions for MyHep All 28 Tablet, Mylan Heads up
| aspect | highlight | details |
|---|---|---|
Alcohol
|
Interaction with alcohol is unknown. Please consult your doctor. | |
Pregnancy
|
PROBABLY SAFE | MyHep All Tablet is probably safe to use during pregnancy. Animal studies have shown low or no adverse effect on the foetus, however, there are limited human studies. Please consult your doctor. |
Lactation
|
MyHep All Tablet is probably safe to use during lactation. Limited human data suggests that the drug does not represent a significant risk to the baby. | |
Driving
|
Do not drive unless you are feeling well. MyHep All Tablet, when taken together with other medicines for the treatment of hepatitis c infection, may produce dizziness, blurred vision and this may affect your ability to drive. | |
Kidney
|
MyHep All Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of MyHep All Tablet may be needed. Please consult your doctor. Limited information is available on the use of MyHep All Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease. | |
Liver
|
safe | MyHep All Tablet is safe to use in patients with liver disease. No dose adjustment of MyHep All Tablet is recommended. However, inform your doctor if you have any kidney disease as regular monitoring of liver function tests may be advised in some patients while taking this medicine. |
Suggestion by Anukar Pharmacy on missing a dose
( MyHep All 28 Tablet, Mylan )
If you miss a dose of the medicines please consult your doctor.Do not double the dose.
Disclaimer
The information of Anukar Pharmacy is for reference purpose only, and Anukar Pharmacy or Anukar Pharmacy or Anukar Pharmacy is not intended to be a replacement of professional medical advice, diagnosis, or treatment. Anukar Pharmacy suggest to ask the advice of a physician or any qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of anything you have learned from Anukar Pharmacy.
| 药名 | 吉三代, 丙通沙 |
| 厂家 | 迈兰 |
| 成分 | 400mg索非布韦和100mg维帕他韦 |
| 说明 |
吉三代
吉三代以Epclusa等品牌销售，是一种用于治疗丙型肝炎的固定剂量组合药物，是口服药。它结合了sofosbuvir和velpatasvir。丙型肝炎基因型 1到6的有效率超过90％。
治疗作用：吉三代是索非布韦，一个丙型肝炎病毒(HCV)NS5B聚合酶抑制剂核苷酸类似物，和velpatasvir，一种HCV NS5A抑制剂的一个固定-剂量剂量组合，和适用为有慢性HCV基因型 1，2，3，4，5或6感染成年患者的治疗：⑴无硬化或有代偿的硬化⑵为与利巴韦林为有失代偿硬化联合使用。丙肝
|
* 以上中文信息由印度阿努卡药房收集的MyHep All 28 Tablet, Mylan（吉三代, 丙通沙）中文网络信息和软件翻译获得，阿努卡药房认为MyHep All 28 Tablet, Mylan（吉三代, 丙通沙）中文产品介绍信息存在与MyHep All 28 Tablet, Mylan（吉三代, 丙通沙）实际数据不一致的可能。阿努卡药房请用户把MyHep All 28 Tablet, Mylan（吉三代, 丙通沙）页面数据作为参考。印度阿努卡药房建议用户在实际使用MyHep All 28 Tablet, Mylan（吉三代, 丙通沙）数据或者信息时，以MyHep All 28 Tablet, Mylan（吉三代, 丙通沙）制造商公开发布的MyHep All 28 Tablet, Mylan（吉三代, 丙通沙）商品信息为参考。使用方法，以用户医生建议使用MyHep All 28 Tablet, Mylan（吉三代, 丙通沙）决定为参考。用户任何关于MyHep All 28 Tablet, Mylan（吉三代, 丙通沙）的建议，可以通知印度阿努卡药房，或通知阿努卡在线客服人员。谢谢
